FEMALE BREAST CARCINOMA

Clinical trials for FEMALE BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new FEMALE BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for FEMALE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo aims to keep advanced breast cancer in check

Disease control Ongoing

This study is testing the safety and feasibility of using two drugs, anastrozole and palbociclib, together to control advanced breast cancer that has spread. It is for postmenopausal women whose cancer is hormone-sensitive and HER2-negative. The trial has two groups: one testing …

Matched conditions: FEMALE BREAST CARCINOMA

Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

FEMALE BREAST CARCINOMA

Get alerted when new FEMALE BREAST CARCINOMA trials appear

New drug duo aims to keep advanced breast cancer in check